AtkinsRéalis Group (ATRL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Apr, 2026Executive summary
Achieved 15% revenue growth to $2.7B in Q2 2025, with organic growth at 9% and record backlog of $21B, driven by strong performance in nuclear and Linxon segments.
Nuclear revenue up 59% to $567M, backlog up 223% to $5.6B, and Engineering Services Regions backlog at $13B, up 6%.
Completed acquisition of David Evans Enterprises for $404M and sale of Highway 407 ETR interest for ~$2.6B, enabling $900M debt repayment and over 9M shares repurchased.
Net income attributable to shareholders surged to $2.3B, driven by a $2.2B after-tax gain on the Highway 407 sale.
Balance sheet now net cash positive, with investment grade ratings and leverage-neutral position.
Financial highlights
Total IFRS revenues up 15% year-over-year to $2.7B; segment-adjusted EBIT up 18% to $246M.
Adjusted EPS from PS and PM rose 59% to $0.78 per diluted share.
Free cash flow for the quarter was -$163M, with operating cash flow expected to exceed $300M for full year 2025.
Segment Adjusted EBITDA from PS & PM increased 30.4% to $244.6M (9.1% margin).
Net cash used for operating activities was $102.4M; cash and equivalents at $953M as of June 30, 2025.
Outlook and guidance
Raised 2025 nuclear revenue outlook to $2.0B–$2.1B, with 11%–13% Segment Adjusted EBIT to revenue ratio.
Lowered 2025 organic revenue growth outlook for Engineering Services Regions to mid-single digits due to USLA and EMEA/AMEA softness.
Segment Adjusted EBITDA to net revenue ratio for Engineering Services Regions guided at 16%–17%.
Corporate SG&A expenses expected at $120M–$130M for PS & PM.
All other 2025 financial outlook metrics maintained.
Latest events from AtkinsRéalis Group
- Record 2024 results, $2.8B asset sale, and strong 2025 growth outlook.ATRL
Q4 202428 Apr 2026 - Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 20257 Apr 2026 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 20243 Feb 2026 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight Q2 2024.ATRL
Q2 20241 Feb 2026 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 202414 Jan 2026 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 202519 Nov 2025 - Q3 2025 saw double-digit revenue and EPS growth, record backlog, and raised Nuclear guidance.ATRL
Q3 202513 Nov 2025